Recent Publications, Information and Events.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 123
- Publication type:
- Article
Works matching IS 10109609 AND DT 2010 AND VI 24 AND IP 2
Results: 24
1
2
Sulfadoxine and pyrimethamine tablets.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 118
- Publication type:
- Article
3
The International Pharmacopoeia.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 115
- Publication type:
- Article
4
Paediatric Medicines Regulators Network.
- Published in:
- 2010
- Publication type:
- Proceeding
5
Rotarix oral vaccine: new information.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 113
- Publication type:
- Article
6
Docetaxel: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 112
- Publication type:
- Article
7
Panitumumab: hypersensitivity reactions.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 110
- Publication type:
- Article
8
Sitimagene ceradenovec: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 112
- Publication type:
- Article
9
Rosiglitazone: authorization suspended.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 111
- Publication type:
- Article
10
Bufexamac : revocation of marketing authorization.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 111
- Publication type:
- Article
11
Ceftobiprole medocaril: discontinuation of sale.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 111
- Publication type:
- Article
12
Albinterferon alfa-2b: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 112
- Publication type:
- Article
13
Becaplermin contraindicated in cancer patients.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 109
- Publication type:
- Article
14
Entacapone/carbidopa/levodopa: prostate cancer.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 109
- Publication type:
- Article
15
Combination of niacin/laropiprant and simvastatin: myopathy.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 108
- Publication type:
- Article
16
Human immune globulin: intravascular haemolysis.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 106
- Publication type:
- Article
17
Saquinavir mesylate: prolongation of QT and PR intervals.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 106
- Publication type:
- Article
18
Leflunomide and peripheral neuropathy.
- Published in:
- 2010
- Publication type:
- Excerpt
19
Irinotecan-induced severe neutropenia: UGT1A1 variant alleles.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 107
- Publication type:
- Article
20
Corrigendum.
- Published in:
- 2010
- Publication type:
- Correction Notice
21
Essential Medicines.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 98
- By:
- Publication type:
- Article
22
Regulatory Harmonization.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 91
- Publication type:
- Article
23
WHO Prequalfication of Medicines Programme.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 87
- Publication type:
- Article
24
WHO Prequalification Programmes.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 2, p. 83
- Publication type:
- Article